Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

What is laser photocoagulation? A laser procedure that seals leaking blood vessels to slow vision loss in wet age-related ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...

Cheap, versatile and packed with antioxidants, watercress is the UK's overlooked superfood. Here's what it does for your skin ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition affects the back of the eye where light is processed by ...

Beloved actress Judi Dench has previously opened up about suffering from macular degeneration, but now claims she's 'hopeless ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...